|
Originally published In Press as doi:10.1074/jbc.M104416200 on August 10, 2001
J. Biol. Chem., Vol. 276, Issue 41, 38023-38028, October 12, 2001
Effect of Insulin on Cell Cycle Progression in MCF-7 Breast
Cancer Cells
DIRECT AND POTENTIATING INFLUENCE*
James
Chappell ,
J. Wayne
Leitner,
Scott
Solomon,
Inga
Golovchenko,
Marc L.
Goalstone , and
Boris
Draznin§
From the Research Service of the Department of Veterans Affairs,
Denver, Colorado 80220
We recently demonstrated that in MCF-7 breast
cancer cells, insulin promoted the phosphorylation and activation of
geranylgeranyltransferase I (GGTI-I), increased the amounts of
geranylgeranylated Rho-A and potentiated the transactivating activity
of lysophosphatidic acid (LPA) (Chappell, J., Golovchenko, I., Wall,
K., Stjernholm, R., Leitner, J., Goalstone, M., and Draznin, B. (2000)
J. Biol. Chem. 275, 31792-31797). In the present
study, we explored the mechanism of this potentiating effect of insulin
on LPA. Insulin (10 nM) potentiated the ability of LPA to
stimulate cell cycle progression and DNA synthesis in MCF-7 cells. The
potentiating effect of insulin appears to involve increases in the
expression of cyclin E and decreases in the expression of the
cyclin-dependent kinase inhibitor p27Kip1. All
potentiating effects of insulin were inhibited in the presence of an
inhibitor of GGTase I, GGTI-286 (3 µM) or by an
expression of a dominant negative mutant of Rho-A. In contrast to its
potentiating action, a direct mitogenic effect of insulin in MCF-7
cells involves activation of phosphatidylinositol 3-kinase and
increased expression of cyclin D1. We conclude that
the ability of insulin to increase the cellular amounts of
geranylgeranylated Rho-A results in potentiation of the LPA effect on
cyclin E expression and degradation of p27Kip1 and cell
cycle progression in MCF-7 breast cancer cells.
*
This work was supported by the Veterans Affairs Research
Service and grants from the American Diabetes Association and the Foundation for Biomedical Education and Research.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipients of the Veterans Affairs Career Development Award.
§
To whom correspondence should be addressed: Veterans Affairs
Hospital (151), 1055 Clermont St., Denver, CO 80220. Tel.:
303-393-4619; Fax: 303-377-5686; E-mail:
Boris.Draznin@med.va.gov.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Gunter, D. R. Hoover, H. Yu, S. Wassertheil-Smoller, T. E. Rohan, J. E. Manson, J. Li, G. Y. F. Ho, X. Xue, G. L. Anderson, et al.
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
J Natl Cancer Inst,
January 7, 2009;
101(1):
48 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. K. Neilson, C. M. Friedenreich, N. T. Brockton, and R. C. Millikan
Physical Activity and Postmenopausal Breast Cancer: Proposed Biologic Mechanisms and Areas for Future Research
Cancer Epidemiol. Biomarkers Prev.,
January 1, 2009;
18(1):
11 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Ye
Lysophospholipid signaling in the function and pathology of the reproductive system
Hum. Reprod. Update,
September 1, 2008;
14(5):
519 - 536.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|